Blood-Based Tumor Mutation Burden As A Predictive Biomarker For Clinical Benefit Of Immunotherapy In Small-Cell Lung Cancer

X. Hu,M. Yuan,Y. Feng,T. Zhang, L. Zhang,G. Dong, H. Zhu, Y. Liu, P. Xing, H. Wang, B. Li,Y. Shi,R. Chen,X. Xia

Journal of Thoracic Oncology（2021）

引用 0|浏览14

暂无评分

关键词

small-cell lung cancer, next-generation sequencing, blood-based tumor mutation burden

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要